The world expects more from pharma. The reality is we have no shortage of promising treatment candidates, yet developing a drug today costs 30x more than it did 10 years ago – as potentially life-saving drugs remain on the shelf. DrugDev is not interested in making clinical trials a little faster or a little better, because incremental improvements to the process are no longer acceptable. The world demands and deserves a truly disruptive revolution on an enterprise scale that flips the economics of clinical trials. We believe the only solution is to take advantage of unified and modern technology (as opposed to the disparate, clunky systems of the past) that bring study teams and sites together to do more trials and bring more drugs to patients who need them.